Search

Author/Creator Song, Gregory

1. ACT-13 DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY. (3rd December 2022)

Authors:
Yoshiki, Arakawa; Reardon, David; Narita, Yoshitaka; Goldlust, Samuel; Anstass, George; McMullen, Dragana; Dow, Edward; Seki, Masataka; Furuta, Yudai; Song, Gregory; Colman, Howard
Journal:
Neuro-oncology advances
Issue:
Volume 4(2022)Supplement 3
Page Start:
iii8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Issue 10 (October 2018)

Authors:
Locatelli, Franco; Mauz-Koerholz, Christine; Neville, Kathleen; Llort, Anna; Beishuizen, Auke; Daw, Stephen; Pillon, Marta; Aladjidi, Nathalie; Klingebiel, Thomas; Landman-Parker, Judith; Medina-Sanson, Aurora; August, Keith; Sachs, Jessica; Hoffman, Kristen; Kinley, Judith; Song, Sam; Song, Greg...
Journal:
Lancet
Issue:
Volume 5:Issue 10(2018)
Page Start:
e450
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma. Issue 9 (2nd September 2021)

Authors:
Song, Yuqin; Guo, Ye; Huang, Huiqiang; Li, Wei; Ke, Xiaoyan; Feng, Jifeng; Xu, Wei; Miao, Harry; Kinley, Judith; Song, Gregory; Dai, Yi; Wang, Hui; Zhu, Jun
Journal:
Expert review of hematology
Issue:
Volume 14:Issue 9(2021)
Page Start:
867
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Population Pharmacokinetic Modeling and Exposure–Response Assessment for the Antibody‐Drug Conjugate Brentuximab Vedotin in Hodgkin's Lymphoma in the Phase III ECHELON‐1 Study. Issue 6 (9th July 2019)

Authors:
Suri, Ajit; Mould, Diane R.; Song, Gregory; Collins, Graham P.; Endres, Christopher J.; Gomez‐Navarro, Jesús; Venkatakrishnan, Karthik
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 106:Issue 6(2019)
Page Start:
1268
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Population Pharmacokinetics of Brentuximab Vedotin in Adult and Pediatric Patients With Relapsed/Refractory Hematologic Malignancies: Model‐Informed Hypothesis Generation for Pediatric Dosing Regimens. (28th June 2020)

Authors:
Suri, Ajit; Mould, Diane R.; Song, Gregory; Kinley, Judith; Venkatakrishnan, Karthik
Journal:
Journal of clinical pharmacology
Issue:
Volume 60:Number 12(2020)
Page Start:
1585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. RTID-03. DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY. (14th November 2022)

Authors:
Reardon, David A; Narita, Yoshitaka; Arakawa, Yoshiki; Goldlust, Samuel; Anstass, George; McMullen, Dragana; Dow, Edward; Seki, Masataka; Furuta, Yudai; Song, Gregory; Colman, Howard
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii249
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗